Mediated by E2F1, SLC16A1-AS1 could progress bladder cancer to the invasive stage (Logotheti et al., 2020) and serve as a new diagnostic indicator in hepatocellular carcinoma (Song et al., 2019; Pei et al., 2020). This evidence concerns the gene SLC16A1 and urinary bladder cancer.